Hyperglycemia-induced activation of the protein kinase C (PKC) pathway represents a critical mechanism in T2DM that associates metabolic disturbances to impaired vascular signaling and cardiovascular complications. The gene discussed is PRRT2; the disease is Hyperglycemia.